论文部分内容阅读
目的:研究探讨雾化吸入在呼吸道疾病中的临床应用效果及应用价值。方法:选取我院收治的呼吸道疾病患者102例作为研究对象,将其随机分为两组,每组51例。对照组患者给予常规综合治疗,观察组患者在对照组的基础上给予复方异丙托溴铵或(和)盐酸氨溴索雾化吸入治疗,比较两组患者主要临床症状的改善情况及治疗有效率。结果:比较两组患者的临床治疗效果可见,观察组患者显效35例,有效14例,无效2例,总的治疗有效率为96.1%;对照组患者显效23例,有效13例,无效15例,总的治疗有效率为70.6%,两组患者的治疗有效率的比较具有显著差异,且P<0.05,具有统计学意义。两组患者的住院时间分别为(6.91±1.35)d和(9.71±1.54)d,比较有显著差异(P<0.05)。两组患者治疗期间均无显著不良反应的出现。结论:雾化吸入治疗呼吸道疾病具有应用范围广、临床疗效显著、安全性好的优点,不仅能有效提高患者的临床治疗有效率,还能缩短患者的住院时间,促进患者早日康复,值得临床推广应用
Objective: To study the effect of nebulized inhalation in respiratory diseases and its clinical value. Methods: A total of 102 patients with respiratory diseases admitted to our hospital were selected as study subjects and randomly divided into two groups (n = 51 in each group). Patients in the control group were given conventional combination therapy. Patients in the observation group were given ipratropium bromide or (and) ambroxol hydrochloride inhalation therapy on the basis of the control group. The improvement of the main clinical symptoms and treatment of the two groups were compared effectiveness. Results: Compared with the clinical treatment effect of two groups of patients, the observation group was markedly effective in 35 cases, effective in 14 cases, ineffective in 2 cases, the total effective rate was 96.1%; control group of patients markedly effective in 23 cases, effective in 13 cases, ineffective in 15 cases , The total effective rate of treatment was 70.6%, the two groups of patients with significant differences in the treatment efficiency, and P <0.05, with statistical significance. The hospital stay of the two groups were (6.91 ± 1.35) d and (9.71 ± 1.54) d, respectively, with significant difference (P <0.05). No significant adverse reactions occurred in both groups during treatment. Conclusion: Atomized inhalation has the advantages of wide range of application, significant clinical efficacy and good safety. It can not only effectively improve the efficiency of clinical treatment, but also shorten the length of hospital stay, promote the early recovery of patients, and worthy of clinical promotion application